FOMC Rate Decision ...
Health Care: Drugs
Dyax Corporation (DYAX: NASDAQ)
$3.13 -0.06 | -1.88%
06/17/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| DYAX | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -20.25 | 49.07 | 21.76 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 12.10 | 1.53 | 0.36 |
| Net Income | -0.53 | 0.00 | |
| EPS | -0.67 | 0.00 |
Earnings for DYAX:
| EBITDA | -16.00 |
| REVENUE | 54.65M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.06 | $-0.05 | $-0.27 | $-0.10 |
| Number of Analysts | 3 | 3 | 3 | 3 |
| High Estimate | $-0.05 | $-0.04 | $-0.23 | $-0.02 |
| Low Estimate | $-0.06 | $-0.07 | $-0.30 | $-0.14 |
| Prior Year | $-0.08 | $-0.05 | $-0.29 | $-0.27 |
| Growth Rate (Year over Year) | 29.17% | -6.67% | 8.05% | 63.75% |
Portfolios with DYAX
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- UserSUPRATRADE-0303071618
- Userdulcinea
- ContributorOptions Action Portfolio Fe...
- UserLast Day of the JPMorgan He...
- UserBarron's Research Reports 7...
- UserPART 6 JPMorgan 26th Annual...
- Userpnp.v
- UserSpec #1
- Userjan's specs
Latest DYAX Headlines from TheStreet
- Commit To Buy Dyax Corp At $2.50, Earn 23.1% Annualized 06.11.13 | 02:06 pm
- 5 Biotech Stocks Poised for Breakouts 07.27.12 | 01:07 pm
- Dyax Corporation CEO Discusses Q2 2012 Results - Earnings Call Transcript 07.19.12 | 08:07 pm
- Dyax's CEO Presents At Deutsche Bank AG Health Care Conference (Transcript) 05.07.12 | 03:05 pm
- Dyax Stock Gaps Down On Today's Open (DYAX) 07.19.11 | 09:07 am
- Dyax Corporation CEO Discusses Q3 2010 Results - Earnings Call Transcript 10.28.10 | 03:10 am
- Dyax Corp. Q2 2010 Earnings Call Transcript 07.28.10 | 10:07 pm
- Merck Buys British Maker Of Biotech Medicines 12.17.09 | 12:12 pm
- Cubist Stops Enrollment In Anti-bleeding Studies 12.03.09 | 01:12 pm
- Delta, Walgreen, Diedrich Coffee Are Big Movers 12.02.09 | 04:12 pm
Press Releases for DYAX
- Dyax Corp. To Participate In The 25th Annual ROTH Conference - Business Wire 03.12.13 | 07:03 am
- Dyax Announces Management Change - Business Wire 03.08.13 | 08:03 am
- Dyax Presents DX-2930 Data At The 2013 American Academy Of Allergy, Asthma And Immunology Annual Meeting - Business Wire 02.25.13 | 07:02 am
- Dyax Corp. To Participate In Upcoming 2013 Healthcare Conferences - Business Wire 02.20.13 | 07:02 am
- Dyax Corp. Announces Fourth Quarter And Full Year 2012 Financial Results - Business Wire 02.13.13 | 04:02 pm
- Dyax Corp. And CVie Therapeutics Announce Partnership To Develop And Commercialize KALBITOR® (ecallantide) For Hereditary Angioedema (HAE) And Other Angioedema Indications In China, Hong Kong And Macau - Business Wire 02.07.13 | 07:02 am
- Dyax Corp. To Participate In The Leerink Swann Global Healthcare Conference - Business Wire 02.06.13 | 07:02 am
- Dyax Corp. To Host Fourth Quarter And Year End 2012 Earnings Call And Webcast - Business Wire 02.05.13 | 07:02 am
- Dyax Corp. And Novellus Biopharma AG Announce Partnership To Develop And Commercialize KALBITOR® (ecallantide) For Hereditary Angioedema (HAE) And Other Angioedema Indications In Latin America - Business Wire 01.31.13 | 07:01 am
- Behind The Success - Research Report On Corcept Therapeutics Inc. And Dyax Corp. - PR Newswire 01.23.13 | 08:01 am
Partner Headlines for DYAX
- Microvision CRASHES 24% to Lead 3 NASDAQ Top Percentage Losers - Wall St. Cheat Sheet 06.18.12 | 09:06 am
- Barclays UPGRADES Dollar General to Overweight and 4 Stocks on Analyst Radars - Wall St. Cheat Sheet 06.15.12 | 04:06 am
- Morning Market Losers - Benzinga 07.19.11 | 09:07 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 07.13.11 | 09:07 am
- Low-Priced Biotech Stocks With Insider Buying - Seeking Alpha 03.18.11 | 06:03 pm
- Dyax Corp. Hits New 52-Week Low (DYAX) - Benzinga 01.04.11 | 09:01 am
- UPDATE 1-Dyax, Sigma-Tau agree to develop, market genetic drug - Reuters 06.21.10 | 08:06 am
- CORRECTED - CORRECTED-UPDATE 1-Dyax posts narrower-than-expected Q4 loss - Reuters 02.17.10 | 09:02 am
